Agenus

Agenus develops and commercializes immunotherapies and vaccines for cancer and infectious diseases.

Agenusbio's scientists, researchers, biotechnologists, physicians, and businesspeople working to bring new medicines to market. Faster. Because they know this isn't about them. It's about the millions of patients waiting to benefit from their discoveries. Co-founded in 1994 by Garo Armen and Pramod Srivastava as Antigenics, their company has outgrown its name but never its raison d'être: to develop and commercialize breakthrough immunotherapies for cancer and infectious diseases. Today they’re reaching far beyond antigens and discovering new ways to speed our their progress. Because they know the patient is waiting. At today’s Agenus (Nasdaq: AGEN), now more than ever before, they are inspired by the power of ideas, by the application of science, and by the deep convictions and commitment they share with their growing circle of partners and collaborators.